CPDC will encourage public-private collaborations through commercial development funding and access to the Centre’s resources. The Centre will support both molecular probe development and translational projects and will implement an IP development and commercialization program designed to help bridge the gap between nascent technologies and those ready for industry investment.
To avoid the inadvertent loss of potentially valuable IP, all recipients of CPDC support through Investigator Sponsored Projects or Fee-for-Service work, must adhere to a pre-publication review process for all public disclosures of results. Pending Disclosures will be submitted to a Disclosure review committee consisting of the principal investigator and a representative from each of the CPDC’s commercialization division and principal investigator’s technology transfer office. The committee will have 30 business days to identify potential IP and request the author(s) to delay publication, not to exceed 60 days, to allow the IP to be protected. If the 30 days pass without notification, the authors are free to publish.
CPDC will foster open collaboration and integration among acadamia and industry working on research and developmental activities. The Centre will avoid duplication of resources already available and maintain a cohesive approach to commercially exploit arising IP. In addition, the Centre will reduce commercialization barriers erected by incompatible cultures and will not seek ownership in relation to IP arising at partner institutions as a result of funding, but will require implementation of oversight mechanisms, including a co-management framework, to ensure that IP is effectively managed. Such oversight and co-management will rely on the following principles:
- Arising IP will be owned by the Institutional employers of the inventors; and
- Subject to an appropriate NDA, the Centre will review freedom to operate issues of arising IP and to the degree they are able, constituents must agree to disclose in writing detailed specifications and descriptions of Background IP that they reasonably expect to be useful or necessary in the research undertaken at the Centre, or for the practice of Centre arising IP and related Project inventions, and
- As IP arises, each Research Partner will assign one representative to sit on an ad hoc Commercialization Advisory Committee (“CAC”). The CAC, which will include industry representatives, will meet on a regular basis to review arising Centre IP and the progress of the Centre’s commercialization strategy and recommend on an “as-required” basis to Executive Director and the Centre’s Management Committee (see below).
- IP developed at the CPDC itself by its staff would be owned by the Centre and managed under an IP Policy that will provide for incentives similar to practices at other academic institutions in Ontario.
The CPDC will also seek to implement an IP development and commercialization investment program designed to encourage industry interactions and leverage developmental funding. Such a program will allow nascent IP to cross the traditional ‘funding gap’ between basic research and industry investment by contributing to the protection and maturation of discoveries resulting from CPDC investments at both the Centre and associate institutions.
Contact us today to learn more about ISRP.
905.525.9140 x 21212